With developing markets on the rise and new breakthroughs in pharmaceuticals, strategy is pivotal. We will help your company navigate new opportunities, mitigate risks, and provide a better understanding of your company’s narrative in the industry.
Fuld + Company analyzed the most common pitfalls that have hampered dozens of product launches.
Amazon recently reached its 20th anniversary this May. It was reported that it had intentions of delving into the multi-billion-dollar pharmacy market.
Despite having positive cardiovascular outcomes data, Amgen's PCSK9 inhibitor, Repatha will not sway payers if the cost-benefit ratio is too high.
Understand the differences between biosimilars and interchangeable pharmaceuticals and how to compete in this extremely crowded marketplace